Planning permission sought for Plot 16 as The Oxford Science Park continues ambitious expansion plans 15,300 sq m of office and lab space to complement the new Bellhouse Building Oxford, UK,…
Read More
27th June 2019 ‒ Blue Earth Diagnostics to become a subsidiary of Bracco Imaging; retains name and management team ‒ ‒ Acquisition driven by lead product Axumin® (fluciclovine F…
Leading gene therapy manufacturer recognised as part of Oxfordshire Business Awards Oxford, UK, June 18 2019 – Its work on life-changing treatments for serious diseases has earned Oxford Biomedica, a…
Turf cutting for the Bellhouse Building to be performed by Lord & Lady Drayson today Oxford, UK, April 24 2019 – The Oxford Science Park, one of the UK’s leading parks…
Oxford, UK – April 16, 2019 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that Axumin (fluciclovine (18F)) has recently been added to the European Association of Urology…
Oxford, UK – March 6, 2019 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, recently celebrated the company’s five year anniversary. During this time, Blue Earth Diagnostics has delivered…
OXFORD BUS COMPANY AND THE OXFORD SCIENCE PARK FORM PARTNERSHIP AS PART OF JOINT DRIVE TO IMPROVE CONNECTIVITY Oxford, UK, March 5 2019 – Oxford Bus Company and The Oxford Science…
Oxford, UK – 4 March 2019 Vaccitech announced today that it has been awarded a contract valued at $8.5 million from the Biomedical Advanced Research and Development Authority (BARDA), a…
Oxford, UK – February 12, 2019 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that the first commercial production of Axumin® (fluciclovine (18F)) in Italy occurred recently,…
Apply now to be recognised as one of Oxfordshire’s best businesses Oxford, UK, 14 January 2019 – Oxfordshire companies which are progressing valuable innovations can apply now for The Oxford…